ArticleNeurocritical care2025
Can Neurocritical Care Guidelines Developed in High-Income Countries be Relevant to Low- and Middle-Income Countries?
Article in Neurocritical care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparative Effectiveness Research in the Americas on Penetrating Brain Injury: The COMPAS-PBI Study Protocol.Neurosurgery practice · 2026Article
- Neuroprognostication After Cardiac Arrest: From Test-Centered Prediction to Ethically Constrained, Longitudinal Decision-Making.Neurocritical care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guideline-concordant care of patients with brain injury may improve outcomes. Guidelines developed in high-income countries (HICs) may overlook important considerations in low- and middle-income countries (LMICs), where resources are often constrained. Many LMICs lack resources for guideline development. Professional societies in HICs can achieve greater worldwide impact through a focus on LMIC concerns during guideline development. Guideline panels that address LMIC concerns should include experts from LMICs and frame population, intervention, comparison, and outcome (PICO) questions appropriate to these settings. The greatest challenge to LMIC-focused guidelines is the paucity of high-quality evidence. Recommendations may be weak or conditional because of reliance on indirect data and observational studies. Methods to evaluate cost-effectiveness developed by the World Health Organization may be useful in addressing the value of system-based interventions such as trauma centers. However, marked variability exists within LMICs in the ability of individuals and centers to access and afford treatments. It is challenging, therefore, for guidelines panels to recommend that expensive but potentially beneficial individual treatment options considered appropriate in HICs not be used in LMICs based on cost considerations alone. Rationing of intensive care unit beds and other resources is unfortunately common in resource-constrained regions. LMIC-focused guidelines on accurate prognostication may allow for better-informed counseling of surrogates and goals of care discussions. This may prevent potentially devastating out-of-pocket expenditure when the probability of meaningful recovery is low. A useful approach to LMIC-focused neurocritical care PICOs may be to posit a situation in which the expensive but potentially beneficial intervention is unavailable, and the question is framed around feasible alternatives in the local environment. This will allow for the possibility that the preferred expensive intervention may be available in some LMIC settings but unavailable in others. Examples include alternative management strategies when tools such as invasive intracranial pressure monitoring or continuous electroencephalography are unavailable. Guidelines that consider LMIC-specific concerns are feasible and may improve the care of critically ill patients with neurological illness worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.